Did you know that cytokine storm, associated with severe infectious processes, is a serious global health problem for which there is no effective drug for treatment?
- Peaches Biotech’s Chief Scientific Officer publishes results of his research against the cytokine storm associated with infectious processes in the book Purinergic System
- The cytokine storm associated with severe infectious processes is a serious global health problem but there is still no drug for its treatment. Dr. Lapuente highlights the need for an immunomodulatory, anti-inflammatory drug to combat the effects of this cytokine storm.
- The chapter published in the book Purinergic System reveals results of high efficacy and safety of PRS® CK STORM as an investigational drug to prevent and treat cytokine storm associated with infectious processes of COVID-19 or any origin.
Madrid, September 19, 2022 – Pedro Lapuente, Chief Scientific Officer of Peaches Biotech Group, a Spanish company specialized in advanced therapies, announces positive results in the development of research with PRS® CK STORM.
Peaches Biotech Group
Peaches Biotech, a Spanish company specialized in advanced therapies, publishes positive results in the development of research with PRS® CK STORM. A drug capable of preventing and combating cytokine storm, an inflammatory response associated with infections such as COVID-19.
Dr. Lapuente publishes the positive results of his research in one of the chapters of the book Purinergic System from IntechOpen, the world’s leading publisher of open access books for scientists.
The proposal of the Peaches Biotech group is presented in this publication, under the title “.Immunomodulatory effects of an M2 conditioned medium (PRS® CK STORM): Theory on the possible complex mechanism of action through anti-inflammatory modulation of the TLR system and the purinergic system”. It is a biological therapy based on the use of an allogeneic conditioned medium derived from M2 macrophages, whose manufacturing base is the co-culture of adult mesenchymal stem cells from fat and allogeneic, with M2 macrophages.
Mesenchymal stem cells, placed in co-culture with macrophages, not only respond to macrophages and adjust their secretome accordingly, but also induce macrophages to respond to them, creating a feedback loop that contributes to immune regulation.
PRS® CK STORM opens the way to a new anti-inflammatory treatment that is presented as a solution to the worldwide problem of severe infectious processes.
In the words of Pedro Lapuente: “the language with which immune cells communicate with the different tissues shows us a way to find new drugs, of biological origin, of great importance as immunomodulators, anti-inflammatories and tissue regenerators“.
In his chapter of the book, Dr. Lapuente highlights the extreme need that exists today for an immunomodulatory, anti-inflammatory drug that is capable of fighting the effects of the cytokine storm associated with infections.